Harvard Bioscience Inc (HBIO)

Harvard Bioscience Inc Azioni (HBIO) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	9.50%22.73	20.76	23.74	20.59	20.45
Cost Of Revenue	18.63%10.10	8.51	9.56	8.57	8.92
Gross Profit	3.15%12.63	12.24	14.17	12.02	11.53
	1.42%13.61	13.42	12.46	11.82	12.35
Research and Development	5.46%2.45	2.33	2.18	2.13	2.19
Other Operating Expenses	35.32%0.32	0.24	0.22	0.05	0.20
Operating Income/Loss	16.70%-0.98	-1.17	1.71	0.20	-0.82
Nonoperating Income/Loss	10.08%-1.92	-2.13	-4.91	-1.33	-1.44
Income/Loss From Continuing Operations Before Tax	12.43%-2.90	-3.31	-3.20	-1.13	-2.25
Income Tax Expense/Benefit	88.03%0.01	0.12	-0.36	0.10	0.03
	15.01%-2.91	-3.42	-2.85	-1.23	-2.28
Attributable To Parent	15.01%-2.91	-3.42	-2.85	-1.23	-2.28
Basic Average Shares	1.18%4.53	4.47	-	44.56	44.30
Diluted Average Shares	1.18%4.53	4.47	-	44.56	44.30
Basic Earnings Per Share	16.88%-0.64	-0.77	-	-0.03	-0.05
Diluted Earnings Per Share	16.88%-0.64	-0.77	-	-0.03	-0.05